Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography–tandem mass spectrometry – A New Zealand perspective of use in 2018

Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.

(2019) Oya Yeter et al.   Drug Testing and Analysis

Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA

(2019) Piotr Adamowicz et al.   CLINICAL TOXICOLOGY

The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017

(2019) R.F. Somerville et al.   FORENSIC SCIENCE INTERNATIONAL

Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography–high resolution mass spectrometry

(2019) Oya Yeter et al.   FORENSIC SCIENCE INTERNATIONAL

Simple screening procedure for 72 synthetic cannabinoids in whole blood by liquid chromatography–tandem mass spectrometry

(2018) Katarzyna Ambroziak et al.   Forensic Toxicology

Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures

(2018) Richard C. Kevin et al.   Forensic Toxicology

The Effect of Lowering the Legal Drink-Drive Limit on the Toxicological Findings in Driver Fatalities: A Comparison of Two Jurisdictions,

(2018) Hilary J. Hamnett et al.   JOURNAL OF FORENSIC SCIENCES

The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)

(2018) Vincenzo Abbate et al.   PURE AND APPLIED CHEMISTRY

Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?

(2018) Maria Antonietta De Luca et al.   CLINICAL THERAPEUTICS

New psychoactive substances detected at the New Zealand border, 2014-2018

(2018) Cameron S. Johnson et al.   Drug Testing and Analysis

Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series

(2017) Bernardino Barceló et al.   FORENSIC SCIENCE INTERNATIONAL

Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA

(2017) V. Angerer et al.   FORENSIC SCIENCE INTERNATIONAL

Detection of metabolites of two synthetic cannabimimetics, MDMB-FUBINACA and ADB-FUBINACA, in authentic human urine specimens by accurate mass LC–MS: a comparison of intersecting metabolic patterns

(2017) Pierce Kavanagh et al.   Forensic Toxicology

Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases

(2017) Kiyotaka Usui et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

(2017) Barry K. Logan et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York

(2017) Axel J. Adams et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?

(2016) Florian Franz et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood

(2016) Marykathryn Tynon et al.   Drug Testing and Analysis

Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples

(2016) Florian Franz et al.   Drug Testing and Analysis

Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples

(2016) Cornelius Hess et al.   Drug Testing and Analysis

Death after use of the synthetic cannabinoid 5F-AMB

(2016) Kevin G. Shanks et al.   FORENSIC SCIENCE INTERNATIONAL

Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA

(2016) Kevin G. Shanks et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

To Measure or Not to Measure? That is the NPS Question

(2016) Dimitri Gerostamoulos et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry

(2016) Jessica L. Knittel et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC–MS/MS and application to real cases

(2016) Fabio Vaiano et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry

(2016) Maria Andersson et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA

(2015) Ariane Wohlfarth et al.   AAPS Journal

Validation of JWH-018 and its metabolites in blood and urine by UPLC–MS/MS: Monitoring in forensic cases

(2015) Yeter Erol Öztürk et al.   FORENSIC SCIENCE INTERNATIONAL

Application of a validated LC–MS/MS method for JWH-073 and its metabolites in blood and urine in real forensic cases

(2015) Serkan Ozturk et al.   FORENSIC SCIENCE INTERNATIONAL

Synthetic Cannabinoid–Related Illnesses and Deaths

(2015) Jordan Trecki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synthetic cannabimimetic agents metabolized by carboxylesterases

(2014) Ragnar Thomsen et al.   Drug Testing and Analysis

Scientific Working Group for Forensic Toxicology (SWGTOX) Standard Practices for Method Validation in Forensic Toxicology

(2013)   JOURNAL OF ANALYTICAL TOXICOLOGY

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity

(2012) Lisa K. Brents et al.   BIOCHEMICAL PHARMACOLOGY

Benzylpiperazine: the New Zealand legal perspective

(2011) T. Bassindale   Drug Testing and Analysis

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Identification and Quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in Human Whole Blood

(2011) S. L. Kacinko et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

(2011) Lisa K. Brents et al.   PLoS One